Stock market today: S&P 500 closes higher in whipsaw session as jobs report looms
Investing.com-- The S&P 500 gave up gains Thursday, as investors assessed a deluge of corporate earnings as well as more ...
Eli Lilly projects 32% revenue growth for 2025, fueled by incretin expansion and new launches
Terence Flynn, Morgan Stanley, inquired about Zepbound payer dynamics and access. Patrik Jonsson explained that Medicare coverage related to obstructive sleep apnea (OSA) is anticipated in the second ...
Wall St ticks higher as big corporate earnings lift sentiment
At 09:52 a.m. ET, the Dow Jones Industrial Average rose 8.51 points, or 0.04%, to 44,892.21, the S&P 500 gained 13.84 points, or 0.23%, to 6,075.32 and the Nasdaq Composite gained 45.93 points, or ...
Mounjaro and Zepbound Sales Soar, Pushing Eli Lilly's (LLY) Q4 Revenue to New Highs
Eli Lilly posts robust Q4 earnings as Mounjaro and Zepbound sales more than double, lifting full-year revenue by 32% ...
Eli Lilly and Company (NYSE:LLY) Trading 0.1% Higher After Analyst Upgrade
Eli Lilly and Company (NYSE:LLY – Get Free Report)’s stock price rose 0.1% on Tuesday after Truist Financial raised their price target on the stock from $1,029.00 to $1,038.00. Truist Financial ...